Literature DB >> 2429992

Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia.

R P Dullaart, B Speelberg, H J Schuurman, R W Milne, L M Havekes, Y L Marcel, H J Geuze, M M Hulshof, D W Erkelens.   

Abstract

The presence of apolipoprotein (apo) B in liver and intestine from a patient with abetalipoproteinemia was evaluated by immunohistochemistry with a polyclonal and six monoclonal antibodies to different apo B-48 and B-100 epitopes. In normal liver, apo B was present inside and outside hepatocytes. The patients liver exhibited staining in the cytoplasm with the polyclonal and three monoclonal antibodies. By immunoelectron-microscopy, apo B was found to be present in the smooth endoplasmatic reticulum and the Golgi complex. Normal intestinal epithelium was labeled with polyclonal and all monoclonal antibodies, including those specific for apo B-100. The patients epithelium stained with polyclonal and six monoclonals, and apo B was present in the Golgi complex. Thus, normal intestinal mucosa expressed apo B-48 and B-100 epitopes, which indicates apo B-100 synthesis in the gut. The synthesis of the apo B molecule in the patient seems to be retained in both liver and gut, which suggests a posttranslational defect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429992      PMCID: PMC423844          DOI: 10.1172/JCI112727

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Separation of plasma lipoproteins by density-gradient ultracentrifugation.

Authors:  T G Redgrave; D C Roberts; C E West
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

2.  Malformation of the erythrocytes in a case of atypical retinitis pigmentosa.

Authors:  F A BASSEN; A L KORNZWEIG
Journal:  Blood       Date:  1950-04       Impact factor: 22.113

3.  Localization of apolipoprotein B in intestinal epithelial cells.

Authors:  R M Glickman; J Khorana; A Kilgore
Journal:  Science       Date:  1976-09-24       Impact factor: 47.728

4.  Intestinal apoproteins during fat absorption.

Authors:  G Schonfeld; E Bell; D H Alpers
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

Review 5.  Abetalipoproteinemia.

Authors:  H J Kayden
Journal:  Annu Rev Med       Date:  1972       Impact factor: 13.739

6.  Long-term management of abetalipoproteinaemia. Possible role for vitamin E.

Authors:  D P Muller; J K Lloyd; A C Bird
Journal:  Arch Dis Child       Date:  1977-03       Impact factor: 3.791

7.  A study of positive staining of ultrathin frozen sections.

Authors:  K T Tokuyasu
Journal:  J Ultrastruct Res       Date:  1978-06

8.  Apoprotein B in fasting and postprandial human jejunal mucosa.

Authors:  D Rachmilewitz; J J Albers; D R Saunders
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

9.  Improved procedures for immunoferritin labeling of ultrathin frozen sections.

Authors:  K T Tokuyasu; S J Singer
Journal:  J Cell Biol       Date:  1976-12       Impact factor: 10.539

10.  Subcellular localization of B apoprotein of plasma lipoproteins in rat liver.

Authors:  C A Alexander; R L Hamilton; R J Havel
Journal:  J Cell Biol       Date:  1976-05       Impact factor: 10.539

View more
  10 in total

1.  Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48.

Authors:  A Curtin; P Deegan; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

2.  Genetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia.

Authors:  P J Talmud; J K Lloyd; D P Muller; D R Collins; J Scott; S Humphries
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

3.  Development and partial characterisation of an antiserum against apolipoprotein B of the short-finned eel, Anguilla australis.

Authors:  Erin L Damsteegt; Hiroko Mizuta; Yuichi Ozaki; Naoshi Hiramatsu; Takashi Todo; Akihiko Hara; Shigeho Ijiri; Shinji Adachi; P Mark Lokman
Journal:  J Comp Physiol B       Date:  2014-03-11       Impact factor: 2.200

Review 4.  Apolipoproteins in lipid transport, an impressionist view.

Authors:  D W Erkelens
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

5.  Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.

Authors:  M F Linton; R Gish; S T Hubl; E Bütler; C Esquivel; W I Bry; J K Boyles; M R Wardell; S G Young
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

6.  Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia.

Authors:  D R Collins; T J Knott; R J Pease; L M Powell; S C Wallis; S Robertson; C R Pullinger; R W Milne; Y L Marcel; S E Humphries
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

7.  Exclusion of linkage between the human apolipoprotein B gene and abetalipoproteinemia.

Authors:  L S Huang; P A Jänne; J de Graaf; M Cooper; R J Deckelbaum; H Kayden; J L Breslow; R J Decklebaum
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

8.  Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in a nonhepatic cell line.

Authors:  R N Thrift; J Drisko; S Dueland; J D Trawick; R A Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia.

Authors:  T M Narcisi; C C Shoulders; S A Chester; J Read; D J Brett; G B Harrison; T T Grantham; M F Fox; S Povey; T W de Bruin
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

10.  Human apolipoprotein B (apoB) mRNA: identification of two distinct apoB mRNAs, an mRNA with the apoB-100 sequence and an apoB mRNA containing a premature in-frame translational stop codon, in both liver and intestine.

Authors:  K Higuchi; A V Hospattankar; S W Law; N Meglin; J Cortright; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.